Page 82 - Read Online
P. 82

Page 6 of 13                                              Farrell et al. Hepatoma Res 2020;6:18  I  http://dx.doi.org/10.20517/2394-5079.2019.019



                 Median follow up of 13 months so  longer term survival results may  not be truly reflective of the general   population  Retrospective case series with  selection bias for patients who   underwent liver biopsy  ALT is not always an accurate  diagnostic marker for NAFLD and  this method may be underestimate  prevalence in both NAFLD and control   No clear definition of NAFLD used  Retrospective design and cohort  derived from a tertiary referral centre  wh















                 53.8%                   56.6%        80%    group  N/A     63%




                 46.2% of NAFLD associated HCC  were non-cirrhotic compared to 2.8%   in those with HCV 73.1% of NAFLD-related HCC patients  have diabetes mellitus compared  with only 24.9% of HCV-related HCC   patients NAFLD HCC detected at later stage,  had larger volume and more infiltrative  pattern compared to HCV-related HCC Non-significant survival difference  NAFLD 28.5 months vs. 35 months in   HCV 43.4% of NAFLD-related HCC  occurred with a non-cirrhotic liver N
















                 NAFLD if all other known  aetiologies of liver disease could  be ruled out and if consistent  present or past histological or ultra  sonographic features of fatty liver  and alcohol intake < 30 g/day  Histologically  2 or more elevated ALT values (>  40 IU/mL for men and > 31 IU/ mL for women) in the outpatient  setting in the absence of other  causes of liver disease or any ICD   codes for alcohol use  Medical chart review  NAFLD defined by no other caus











                                                      296,707                          30
                 145                     83                        272      225





                 Multicentre   observational   prospective cohort of   patients with NAFLD-  related HCC  Retrospective analysis   of patients diagnosed   with HCC and NAFLD   at the Cleveland Clinic   between 2003 and   2012  Prospective   longitudinal cohort of   NAFLD patients with   matched controls  Multicentre   prospective cohort of   newly diagnosed HCC   between 2012 and   2013  Single centre   retrospective cohort   study of all HCC   patients at Karolinska   Un






                 Italy                   USA          USA          Australia  Sweden

                 Piscaglia et al. [49]   Mohamad et al. [48]  Kanwal et al. [32]    Hong et al. [42]  Bengtsson et al. [52]
   77   78   79   80   81   82   83   84   85   86   87